1-4 of 4
Stephen G. O'Brien, BSc (Hons) PhD MBChB FRCP MRCPath
Close
Sort by
Journal Articles

Chronic Myeloid Leukaemia Patients with Stable Molecular Responses (at least MR3) May Safely Decrease the Dose of Their Tyrosine Kinase Inhibitor: Data from the British Destiny Study

Richard E. Clark, MD, Fotios Polydoros, MSc, Jane F. Apperley, MD, Christopher Pocock, Graeme Smith, MD, Jenny L Byrne, FRCP FRCPath PhD, Stephen G. O'Brien, BSc (Hons) PhD MBChB FRCP MRCPath, Tony Coffey, Letizia Foroni, MD PhD, Mhairi Copland, BSc (Hons) MB ChB PhDFRCP FRCPath
Journal: Blood
Blood (2016) 128 (22): 938.
https://doi.org/10.1182/blood.V128.22.938.938
Published: 2016
Journal Articles

Reliable Detection of Abl Tyrosine Kinase Domain Mutations to <1% Using NGS Data Quality Parsing and Corroboration of Overlapping Paired-End Sequences

Jacqueline Dickson, PhD, Nick Kennedy, MBBS MA Cantab FRACP, Leanne M. Cork, BSc (Hons), Letizia Foroni, MDPhDFRCPath, Corinne A. Hedgley, BSc (Hons), Mhairi Copland, BSc (Hons) MB ChB PhDFRCP FRCPath, Tessa L. Holyoake, MDPhD, Stephen G. O'Brien, BSc (Hons) PhD MBChB FRCP MRCPath, Bernard Ramashoye, PhDMRCP FRCPath
Journal: Blood
Blood (2015) 126 (23): 4021.
https://doi.org/10.1182/blood.V126.23.4021.4021
Published: 2015
Journal Articles

Assessment of Quality of Life in the NCRI Spirit 2 Study Comparing Imatinib with Dasatinib in Patients with Newly-Diagnosed Chronic Phase Chronic Myeloid Leukaemia

Alexander M. Labeit, MDPhD, Mhairi Copland, BSc (Hons) MB ChB PhDFRCP FRCPath, Leanne M. Cork, BSc (Hons), Corinne A. Hedgley, BSc (Hons), Letizia Foroni, MDPhDFRCPath, Wendy L. Osborne, MBBS (Hons) MRCP FRCPath, Gemma Gills, MSc BSc (Hons), Jane F. Apperley, MD, Tessa L. Holyoake, MDPhD, Ruth V. Bescoby, MSc BSc, Christopher Pocock, Thomas Zwingers, MSc, Philippa Burnell, Jenny L. Byrne, PhD, John H. McCullough, John M. Goldman, DM FRCP FRCPath, Richard E. Clark, MD, Stephen G. O'Brien, BSc (Hons) PhD MBChB FRCP MRCPath
Journal: Blood
Blood (2015) 126 (23): 4024.
https://doi.org/10.1182/blood.V126.23.4024.4024
Published: 2015
Journal Articles

Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML

Stephen G O'Brien, BSc (Hons) PhD MBChB FRCP MRCPath, Corinne Hedgley, BSc, Sarah Adams, BSc MSc, Letizia Foroni, MDPhD, Jane F. Apperley, MD, Tessa L Holyoake, MDPhDFRSE FMedSci, Christopher Pocock, MD PhD, Jenny L Byrne, MB ChB PhDFRCP FRCPath, Lynn Margaret Seeley, MSc RN NDN, Wendy L Osborne, MBBS(Hons) MRCP FRCPath, John M Goldman, DM, Mhairi Copland, BSc PhDFRCP FRCPath, Richard E Clark, MA, MD
Journal: Blood
Blood (2014) 124 (21): 517.
https://doi.org/10.1182/blood.V124.21.517.517
Published: 2014